Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 2025

Genotype-guided pharmacotherapy: the challenges of integrating pharmacogenomic testing into routine healthcare with a focus on experiences at a single site.

View Full Paper
Ask AI
Bookmark
Share

Authors

LCLarisa H. CavallariECEmily J. CicaliMNMadeline Norris

Discussion

Loading...

Member takes

Overview

Challenges of PGx testing integration in clinical settings impact drug therapy success, highlighting reimbursement and EHR issues.

Key Points

  • Pharmacogenetic testing faces integration challenges in routine healthcare, impacting drug response.
  • Evidence suggests that genetic contributions to drug response are significant, yet PGx testing remains underutilized.
  • Our institution's early adoption of PGx testing provided clinical decision support for various medications, underscoring the benefits.
  • Legislative efforts and EHR vendor improvements may enhance the integration and reimbursement of PGx testing.

Cite This Study

Cavallari et al. (2025) studied this question.

synapsesocial.com/papers/68dd89defe798ba2fc497e5fhttps://doi.org/10.1080/17512433.2025.2568089
View Full Paper
Ask AI
Bookmark
Share